Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. is dated December 2, 2025. The report serves to distribute materials for a Special General Meeting of Shareholders scheduled for January 7, 2026. The record date for shareholders entitled to vote is December 10, 2025.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on the administrative details of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing incorporates by reference the Notice of Meeting, Proxy Statement, and Proxy Card as Exhibits 99.1, 99.2, and 99.3. It does not contain management commentary, financial guidance, or specific risk disclosures within the main body text. The filing is incorporated into the Company's Registration Statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- Special General Meeting of Shareholders is scheduled for January 7, 2026.
- Shareholder record date for voting eligibility is December 10, 2025.
- Details regarding the specific agenda items for the meeting are contained in the attached Proxy Statement (Exhibit 99.2), not in this summary text.
- The filing is signed by Eyal Shamir, Chief Executive Officer.